Literature DB >> 22922523

Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation.

Ashok Srinivasan1, Chong Wang, Deo K Srivastava, Ken Burnette, Jerry L Shenep, Wing Leung, Randall T Hayden.   

Abstract

Advances made in the field of hematopoietic stem cell transplantations (HSCT) over the past 20 years may have had an impact on the distribution of posttransplantation infections. We sought to retrospectively analyze the epidemiology and risk factors for bacterial, fungal, and viral infections in children after allogeneic HSCT in a cohort of 759 children who underwent allogeneic HSCT in a single institution between 1990 and 2009. The association between infections and risk factors of interest at 0 to 30 days, 31 to 100 days, and 101 days to 2 years posttransplantation was evaluated using logistic regression. Difference among the subtypes within each category was studied. There were 243 matched-related donors, 239 matched-unrelated donors (MUDs), and 176 haploidentical donor transplantations. Era of transplantation (0-30 days), peripheral blood stem cell product, acute graft-versus-host disease (aGVHD; 31-100 days), and chronic GVHD (cGVHD; 101-730 days) were associated with higher risk for bacterial infections at the respective time periods. Patients with aGVHD (31-100 days), cGVHD, and older age (101-730 days) were at higher risk for fungal infections. Cytomegalovirus (CMV) donor/recipient (D/R) serostatus (0-100 days), era of transplantation, MUD HSCT (31-100 days), and cGVHD (101-730 days), influenced viral infections. Gram-positive outnumbered gram-negative bacterial infections; aspergillosis and candidemia were equally prevalent in all time periods. Haploidentical donor HSCT was not associated with an increased risk of infections. There seems to be a continuum in the timeline of infections posttransplantation, with bacterial, fungal, and viral infections prevalent in all time periods, particularly late after the transplantation, the risk affected by GVHD, CMV, D/R status, product type, older age, and use of unrelated donors.
Copyright © 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22922523      PMCID: PMC3554248          DOI: 10.1016/j.bbmt.2012.08.012

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  33 in total

Review 1.  Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.

Authors:  F Aversa
Journal:  Bone Marrow Transplant       Date:  2008-01-07       Impact factor: 5.483

2.  Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease.

Authors:  Nathan Cantoni; Hans H Hirsch; Nina Khanna; Sabine Gerull; Andreas Buser; Christoph Bucher; Jörg Halter; Dominik Heim; André Tichelli; Alois Gratwohl; Martin Stern
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-29       Impact factor: 5.742

3.  High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia.

Authors:  Wing Leung; Dario Campana; Jie Yang; Deqing Pei; Elaine Coustan-Smith; Kwan Gan; Jeffrey E Rubnitz; John T Sandlund; Raul C Ribeiro; Ashok Srinivasan; Christine Hartford; Brandon M Triplett; Mari Dallas; Asha Pillai; Rupert Handgretinger; Joseph H Laver; Ching-Hon Pui
Journal:  Blood       Date:  2011-05-25       Impact factor: 22.113

4.  Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

Authors:  Dimitrios P Kontoyiannis; Kieren A Marr; Benjamin J Park; Barbara D Alexander; Elias J Anaissie; Thomas J Walsh; James Ito; David R Andes; John W Baddley; Janice M Brown; Lisa M Brumble; Alison G Freifeld; Susan Hadley; Loreen A Herwaldt; Carol A Kauffman; Katherine Knapp; G Marshall Lyon; Vicki A Morrison; Genovefa Papanicolaou; Thomas F Patterson; Trish M Perl; Mindy G Schuster; Randall Walker; Kathleen A Wannemuehler; John R Wingard; Tom M Chiller; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2010-04-15       Impact factor: 9.079

5.  Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  S Schönberger; R Meisel; O Adams; Y Pufal; H J Laws; J Enczmann; D Dilloo
Journal:  Biol Blood Marrow Transplant       Date:  2010-04-24       Impact factor: 5.742

6.  Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors.

Authors:  W H Leung; V Turner; S L Richardson; E Benaim; G Hale; E M Horwitz; P Woodard; L C Bowman
Journal:  Hum Immunol       Date:  2001-04       Impact factor: 2.850

7.  Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.

Authors:  Malgorzata Mikulska; Valerio Del Bono; Anna Maria Raiola; Barbara Bruno; Francesca Gualandi; Domenico Occhini; Carmen di Grazia; Francesco Frassoni; Andrea Bacigalupo; Claudio Viscoli
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

8.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

9.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Authors:  D Neofytos; D Horn; E Anaissie; W Steinbach; A Olyaei; J Fishman; M Pfaller; C Chang; K Webster; K Marr
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

10.  Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated.

Authors:  D D Poutsiaka; D Munson; L L Price; G W Chan; D R Snydman
Journal:  Bone Marrow Transplant       Date:  2010-05-17       Impact factor: 5.483

View more
  35 in total

1.  Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.

Authors:  J A Hol; T F W Wolfs; M B Bierings; C A Lindemans; A B J Versluys; A Wildt de; C E Gerhardt; J J Boelens
Journal:  Bone Marrow Transplant       Date:  2013-10-14       Impact factor: 5.483

2.  Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa.

Authors:  Pier Giorgio Cojutti; Natalia Maximova; Giulia Schillani; William Hope; Federico Pea
Journal:  J Antimicrob Chemother       Date:  2019-06-01       Impact factor: 5.790

Review 3.  Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Authors:  Marie-Céline Zanella; Samuel Cordey; Laurent Kaiser
Journal:  Clin Microbiol Rev       Date:  2020-08-26       Impact factor: 26.132

4.  Effectiveness of Bath Wipes After Hematopoietic Cell Transplantation: A Randomized Trial.

Authors:  Margie Kjellin; Amr Qudeimat; Emily Browne; Dinesh Keerthi; Anusha Sunkara; Guolian Kang; Alicia Winfield; Mary Anne Giannini; Gabriela Maron; Randall Hayden; Wing Leung; Brandon Triplett; Ashok Srinivasan
Journal:  J Pediatr Oncol Nurs       Date:  2020-07-24       Impact factor: 1.636

5.  Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

Authors:  Holly K Miller; Thomas M Braun; Terri Stillwell; Andrew C Harris; Sung Choi; James Connelly; Daniel Couriel; Steven Goldstein; Carrie L Kitko; John Magenau; Attaphol Pawarode; Pavan Reddy; Mary Riwes; Gregory A Yanik; John E Levine
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-22       Impact factor: 5.742

6.  Pre-hematopoietic stem cell transplant lung function and pulmonary complications in children.

Authors:  Ashok Srinivasan; Saumini Srinivasan; Sudeep Sunthankar; Anusha Sunkara; Guolian Kang; Dennis C Stokes; Wing Leung
Journal:  Ann Am Thorac Soc       Date:  2014-12

7.  Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience.

Authors:  A Srinivasan; L McLaughlin; C Wang; D K Srivastava; D R Shook; W Leung; R T Hayden
Journal:  Transpl Infect Dis       Date:  2013-11-21       Impact factor: 2.228

Review 8.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Authors:  Juan Gea-Banacloche; Krishna V Komanduri; Paul Carpenter; Sophie Paczesny; Stefanie Sarantopoulos; Jo-Anne Young; Nahed El Kassar; Robert Q Le; Kirk R Schultz; Linda M Griffith; Bipin N Savani; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

Review 9.  Fungal infections in children with haematologic malignancies and stem cell transplant recipients.

Authors:  William R Otto; Abby M Green
Journal:  Br J Haematol       Date:  2020-03-11       Impact factor: 6.998

10.  Cellular immune function monitoring after allogeneic haematopoietic cell transplantation: evaluation of a new assay.

Authors:  M Israeli; T Klein; C Herscovici; R Ram; O Shpilberg; B Sredni; M Yeshurun
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.